Business Context and Reporting Period
Company: Aspen Insurance Holdings Limited
Filing Type: Form 8-K (Current Report)
Date of Report: October 11, 2006
Event: Entry into a Material Definitive Agreement regarding a new credit facility.
Key Financial Metrics
This filing reports on a specific financing arrangement rather than periodic financial performance. Key metrics include:
- Facility Size: $300 million committed letter of credit facility.
- Collateral Requirement: Increased from 100% to either 111.111111% or 117.647% of the aggregate credit outstanding, depending on the security type pledged.
- Counterparty: Citibank Europe plc (formerly Citibank Ireland Financial Services plc).
- Subsidiary Involved: Aspen Insurance Limited ("Aspen Bermuda").
The filing text does not provide values for revenue, profit, cash flow, margins, or total debt levels.
Material Changes
The primary material change is the execution of a new $300 million collateralized letter of credit facility on October 11, 2006. Additionally, the collateralization terms under the existing Pledge Agreement were modified to require higher collateral coverage ratios (111.111111% or 117.647%) compared to the previous 100% requirement.
Guidance, Outlook, and Risks
Management Commentary: The filing details the legal structure of the new facility, including the Master Agreement, Pledge Agreement, and Assignment Agreement. It notes the assignment of rights from Citibank, N.A. to Citibank Europe plc.
Risks and Contingencies: The filing does not explicitly list new risks or contingencies beyond the obligations inherent in the new credit facility and the increased collateral requirements.
Investor Verification Checklist
- Verify the impact of the increased collateral requirement (111.11% to 117.65%) on the company's liquidity and asset deployment.
- Confirm the specific types of securities pledged to determine which collateral ratio applies.
- Review the full text of the Master Agreement and Pledge Agreement (Exhibits 10.2 and 10.3) for covenants or default triggers.
- Assess the utilization rate of the new $300 million facility relative to the company's total reinsurance obligations.